Spironolactone (drug) ( DrugBank: Spironolactone )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 210 | Single Ventricle | 1 |
210. Single Ventricle
Clinical trials : 51 / Drugs : 53 - (DrugBank : 22) / Drug target genes : 32 - Drug target pathways : 67
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00211081 (ClinicalTrials.gov) | November 2004 | 13/9/2005 | Spironolactone in Patients With Single Ventricle Heart | Impact of Spironolactone on Endothelial Function in Patients With Single Ventricle Heart | Congenital Disorders | Drug: Spironolactone (drug) | Emory University | NULL | Completed | 18 Years | N/A | All | 12 | N/A | United States |